Company: HCTI
Filing Date: 2025-12-10
Form Type: 8-K
Source: 0001213900-25-119878
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-12-10
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Submission of Matters to a Vote of Security Holders.

On December 5, 2025, Healthcare Triangle, Inc.,
a Delaware corporation (the “ Company”) entered into a non-binding advance agreement (the “ Advance Agreement”)
with Teyame A. I. LLC, a St. Kitts and Nevis limited liability company (“ Teyame”), in connection with a proposed acquisition
by the Company of 100% of the equity interests of Teyame 360 S. L. and Datono Mediacion S. L., each a company incorporated in Spain (collectively,
the “ Target Companies”). Teyame serves as the intermediary seller in the contemplated transaction.

The Advance Agreement sets forth a framework for
a potential acquisition with total consideration of up to approximately $50.0 million, consisting of a combination of: (i) cash consideration
of up to approximately $15.0 million payable in tranches, (ii) approximately $6.0 million in shares of the Company’s common stock,
(iii) approximately $24.0 million in shares of the Company’s non-voting convertible preferred stock issuable as post-closing consideration
and convertible six months following closing, and (iv) approximately $5.0 million in shares of the Company’s non-voting convertible
preferred stock issuable as a management earnout, subject to the achievement of to-be agreed post-closing performance targets. The final
purchase price and related terms remain subject to the negotiation and execution of a definitive share purchase agreement.

Pursuant to the Advance Agreement, the Company
has agreed to pay Teyame an advance of $3.0 million in cash on or before December 8, 2025. The advance is intended to be applied against
the cash portion of the purchase price payable at closing, if the transaction is consummated.

If the transaction does not close due to certain
specified circumstances, including, among others, the failure of the parties to agree on the terms of the related definitive purchase
agreement, the occurrence of a material adverse change, inaccurate representations, or governmental or regulatory restrictions outside
the control of the parties, Teyame is required to refund the full $3.0 million advance to the Company within ten business days. If the
transaction fails to close on or before February 16, 2026 due to a delay attributable to the Company, Teyame would be required to refund
$2.5 million of the advance and would be